Mekonos (Series A)

Funding Details
Awarder
Inbox
Date Award
November 09, 2021
Vertical
Synthetic Biology and Personalized Medicine
Funding URL
View Funding Page
Funding Amount:
$25,000,000
Company Info
Founders
Anil Narasimha
Company Description
Mekonos is an enabling technology company transforming synthetic biology and personalized medicine. The company's SoC merges innovations in MEMS, microfluidics, and chemistry for controlled and individualized molecular delivery in cells at scale.
Market
Healthcare
Location
San Francisco, CA, USA
Coinvestors
Debiopharm, Elementum Ventures, Fiscus Ventures, Novartis Pharma AG, Peak6 Investments, Reimagined Ventures, Sands Capital, TDK Ventures
Links
Back to Home Back to Synthetic Biology and Personalized Medicine Deals View Funding Announcement